A Look At Air Products And Chemicals (APD) Valuation After JPMorgan Upgrade And Helium Demand Tailwinds

Why JPMorgan’s upgrade is drawing attention to Air Products and Chemicals (APD)

JPMorgan’s recent upgrade of Air Products and Chemicals (APD), tied to stable earnings and helium market support, has pushed the stock onto more investors’ radars, particularly among those monitoring industrial gases and energy related demand.

See our latest analysis for Air Products and Chemicals.

The recent upgrade comes after a period of building momentum, with a 90 day share price return of 17.89% and a year to date share price return of 16.66%, while the 1 year total shareholder return of 2.64% points to a more modest longer term picture.

If this helium and energy story has your attention, it could be a good moment to see what else is moving in related areas via our 26 power grid technology and infrastructure stocks

With APD up strongly over the last quarter and trading at about a 5% discount to the average analyst price target, the key question is simple: Is there still value on the table, or is the market already pricing in future growth?

Most Popular Narrative: 5% Undervalued

Compared with the last close of $292.19, the most followed narrative pegs Air Products and Chemicals’ fair value at $306.77, leaving a small valuation gap that hinges on how its energy transition projects play out.

Heavy investments in large-scale hydrogen, blue/green ammonia, and carbon capture projects, supported by multi-decade power and supply agreements in growth regions (e.g., Middle East, Asia, U.S. Gulf Coast), are set to come online over the next several years, providing robust and stable earnings and supporting a trajectory of consistently higher operating margins.

Read the complete narrative.

Want to see what sits under that fair value number? The narrative leans on meaningful earnings expansion, firmer margins, and a future earnings multiple that many investors reserve for higher growth stories.

Result: Fair Value of $306.77 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on heavy project spending and helium exposure. Delays, cost overruns or a weaker helium recovery could quickly challenge that underpriced story.

Find out about the key risks to this Air Products and Chemicals narrative.

Another Angle on APD’s Valuation

The narrative fair value of $306.77 suggests APD is modestly undervalued, but the current P/S of 5.3x tells a different story. That is much higher than the US Chemicals industry at 1.1x, the peer average at 4.4x, and the fair ratio of 2.5x, which signals meaningful valuation risk if sentiment cools or expectations reset.

To see whether that elevated sales multiple still stacks up against the underlying business, it is worth stepping through our valuation breakdown in more detail. This includes how the fair ratio could be a level the market moves toward over time, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mix of optimism and caution throughout this article, it makes sense to act quickly, review the latest data, and decide where you stand using the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If APD has sharpened your focus, do not stop here. Broaden your watchlist with targeted stock ideas before the next wave of opportunities moves without you.

• Target potential mispricings by scanning for companies that combine quality and attractive valuations through our 62 high quality undervalued stocks
• Strengthen your income focus by reviewing reliable payers with meaningful yield using the 12 dividend fortresses
• Protect your downside by zeroing in on companies that score well on resilience via the 64 resilient stocks with low risk scores

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com